5-FU	Fluorouracil
ADME	Absorption, distribution, metabolism and excretion
BMP	Bone morphogenetic protein
CEA	Carcinoembryonic antigen
CHT	Caudal hematopoietic tissues
CLSM	Confocal Laser Scanning Microscope
CML	Chronic Myeloid Leukemia
CNN	Convolutional Neural Network
COPAS	Complex Object Parametric Analysis and Sorting
CR	Complete Response
CRC	Colorectal cancer
CRLM	Colorectal Liver Metastases
CROs	Contract Research Organizations
CYP	Human cytochrome P450
DFS	Disease-free survival
dpf	Days post fertilization
ECF	5-Fluorouracil + Cisplatin + Epirubicin
ER	Estrogen receptor
FGF	Fibroblast growth factor
FLOT	Fluorouracil, leucovorin, oxaliplatin and docetaxel
FOLFIRI	5-Fluorouracil + Lederfolin + Irinotecan
FOLFOX	5-Fluorouracil + Lederfolin + Oxaliplatin
FOLFOXIRI	5-Fluorouracil + Folinic acid + Oxaliplatin + Irinotecan
FUCCI4	Fluorescent, ubiquitination-based cell cycle indicator
GBM	Glioblastoma multiforme
GC	Gastric cancer
GEM	Gemcitabine
GEM/nab-P	Gemcitabine + nab-Paclitaxel
GEMOX	Gemcitabine + Oxaliplatin
GFP	Green Fluorescent Protein
Gy	Gray
jak3	Janus kinase 3
LP	Large Particle
mPDX	mouse patient-derived xenografts
MR	Minor Response
MRI	Magnetic resonance imaging
NCI MATCH	National Cancer Institute Molecular Analysis for Therapy Choice
NSCLC	Non-Small Cell Lung Cancer
PCA	Principal component analysis
PD	Progressive Disease
PDAC	Pancreatic ductal adenocarcinoma
PDO	Patient-derived organoids
PDX	Patient-derived xenografts
PFS	Progression-free survival
PR	Progesterone receptor
PR	Partial Response
R-CNN	Regions with Convolutional Neural Network
RECIST	Response Evaluation Criteria In Solid Tumors
RTA	Relative tumor area
SD	Stable Disease
SPIM	Selective Plane Illumination Microscopy
TNBC	Triple-Negative Breast Cancer
VAST	Vertebrate Automated Screening Technology
VEGF	Vascular endothelial growth factor
WHO	World Health Organization
zPDX	Zebrafish patient-derived xenografts